Annual EBITDA
-$4.61 M
-$2.02 M-77.98%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization is currently -$4.61 million, with the most recent change of -$2.02 million (-77.98%) on 01 December 2023. During the last 3 years, it has fallen by -$4.55 million (-8478.03%). LIPO annual EBITDA is now -8478.03% below its all-time high of -$53.70 thousand, reached on 01 December 2020.LIPO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.44 M
-$507.10 K-54.13%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.44 million, with the most recent change of -$507.10 thousand (-54.13%) on 01 September 2024. Over the past year, it has dropped by -$755.70 thousand (-109.81%). LIPO quarterly EBITDA is now -324.80% below its all-time high of -$339.90 thousand, reached on 01 June 2021.LIPO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$4.26 M
-$121.30 K-2.93%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization is currently -$4.26 million, with the most recent change of -$121.30 thousand (-2.93%) on 01 September 2024. Over the past year, it has increased by +$345.80 thousand (+7.51%). LIPO TTM EBITDA is now -595.15% below its all-time high of -$612.90 thousand, reached on 01 March 2021.LIPO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -109.8% | +7.5% |
| 3 y3 years | -8478.0% | -277.0% | -129.2% |
| 5 y5 years | - | - | - |
LIPO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -8478.0% | at low | -302.0% | +5.8% | -129.2% | +10.0% |
| 5 y | 5 years | -8478.0% | at low | -324.8% | +5.8% | -595.1% | +10.0% |
| alltime | all time | -8478.0% | at low | -324.8% | +5.8% | -595.1% | +10.0% |
Lipella Pharmaceuticals Common Stock EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.44 M(+54.1%) | -$4.26 M(+2.9%) |
| June 2024 | - | -$936.80 K(-21.4%) | -$4.14 M(-12.6%) |
| Mar 2024 | - | -$1.19 M(+73.2%) | -$4.74 M(+2.8%) |
| Dec 2023 | -$4.61 M(+78.0%) | -$688.20 K(-48.0%) | -$4.61 M(+7.7%) |
| Sept 2023 | - | -$1.32 M(-13.7%) | -$4.28 M(+16.6%) |
| June 2023 | - | -$1.53 M(+44.3%) | -$3.67 M(+25.8%) |
| Mar 2023 | - | -$1.06 M(+195.8%) | -$2.91 M(+12.6%) |
| Dec 2022 | -$2.59 M | -$359.20 K(-49.6%) | -$2.59 M(-0.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$712.10 K(-8.8%) | -$2.61 M(+7.8%) |
| June 2022 | - | -$780.40 K(+6.0%) | -$2.42 M(+22.2%) |
| Mar 2022 | - | -$736.30 K(+92.2%) | -$1.98 M(+6.6%) |
| Dec 2021 | -$1.86 M(+3361.1%) | - | - |
| Dec 2021 | - | -$383.00 K(-26.8%) | -$1.86 M(+26.0%) |
| Sept 2021 | - | -$522.90 K(+53.8%) | -$1.48 M(+54.9%) |
| June 2021 | - | -$339.90 K(-44.5%) | -$952.80 K(+55.5%) |
| Mar 2021 | - | -$612.90 K | -$612.90 K |
| Dec 2020 | -$53.70 K | - | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly EBITDA year-on-year change?
- What is Lipella Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock TTM EBITDA year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LIPO is -$4.61 M
What is the all time high annual EBITDA for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual earnings before interest, taxes, depreciation & amortization is -$53.70 K
What is Lipella Pharmaceuticals Common Stock quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LIPO is -$1.44 M
What is the all time high quarterly EBITDA for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$339.90 K
What is Lipella Pharmaceuticals Common Stock quarterly EBITDA year-on-year change?
Over the past year, LIPO quarterly earnings before interest, taxes, depreciation & amortization has changed by -$755.70 K (-109.81%)
What is Lipella Pharmaceuticals Common Stock TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LIPO is -$4.26 M
What is the all time high TTM EBITDA for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high TTM earnings before interest, taxes, depreciation & amortization is -$612.90 K
What is Lipella Pharmaceuticals Common Stock TTM EBITDA year-on-year change?
Over the past year, LIPO TTM earnings before interest, taxes, depreciation & amortization has changed by +$345.80 K (+7.51%)